SHIRE PLC: Director Declaration

Director Declaration 
November 15, 2012 - Shire plc (LSE: SHP, NASDAQ: SHPG) announces that, in
accordance with Listing Rule LR 9.6.14, its non-executive director, Anne Minto,
has been appointed as a Non-Executive Director to the Board of Directors of
Tate & Lyle PLC, with effect from December 1, 2012. 
Tony Guthrie
Deputy Company Secretary 
For further information please contact: 
Investor Relations                                                              
                                                                           
Eric Rojas                              erojas@shire.com     +1 781 482 0999   
Sarah Elton-Farr                        seltonfarr@shire.com +44 1256 894157    
Notes to editors 
Shire enables people with life-altering conditions to lead better lives. 
Through our deep understanding of patients' needs, we develop and provide
healthcare in the areas of: 
* Behavioral Health and Gastro Intestinal conditions 


      * Rare Diseases
      * Regenerative Medicine
    as well as other symptomatic conditions treated by specialist physicians.

We aspire to imagine and lead the future of healthcare, creating value for
patients, physicians, policymakers, payors and our shareholders.
                                                                              

Registered in Jersey, No. 99854, 22 Grenville Street, St Helier, Jersey JE4 8PX

Press Release                                     


                                              
www.shire.com 
-0- Nov/15/2012 16:30 GMT
 
 
Press spacebar to pause and continue. Press esc to stop.